RNAZ: TransCode Therapeutics, Inc. Stock

by  •  • Comments Off on RNAZ: TransCode Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 3.92
Enterprise Value ($M) 2.05
Book Value ($M) 1.65
Book Value / Share 3.16
Price / Book 2.38
NCAV ($M) 1.33
NCAV / Share 2.54
Price / NCAV 2.95

Profitability (mra)
Return on Invested Capital (ROIC) -8.27
Return on Assets (ROA) -2.89
Return on Equity (ROE) -9.10

Liquidity (mrq)
Quick Ratio 1.58
Current Ratio 1.58

Balance Sheet (mrq) ($M)
Current Assets 3.61
Assets 3.94
Liabilities 2.28
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
01-03 13G Sabby Management, Llc
11-06 13G/A 3i, LP 0.00 -100.00
06-21 13D Fitzgerald Thomas A 5.50
02-15 13G/A Medarova Zdravka 0.40 -93.25
02-14 13G/A Tang Capital Partners Lp 0.00 -100.00
02-13 13G/A Lind Global Fund II LP 0.10 -98.95

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-04-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-04 77,619 305,782 25.38
2025-02-03 95,439 260,404 36.65
2025-01-31 98,920 255,269 38.75
2025-01-30 181,975 639,434 28.46

(click for more detail)

Similar Companies
RGC – Regencell Bioscience Holdings Limited RGLS – Regulus Therapeutics Inc.
RMTI – Rockwell Medical, Inc. RNTX – Rein Therapeutics Inc.
RNXT – RenovoRx, Inc.


Financial data and stock pages provided by
Fintel.io